NCT01574118

Brief Summary

This study is investigating a new brief psychotherapy for post-traumatic stress disorder (PTSD) which, modifies an already proven psychotherapy for PTSD by adding two new components and modifying several others. The goal of the study is to determine whether this experimental treatment outperforms the well-established standard treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Apr 2012

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 3, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 10, 2012

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

August 29, 2022

Status Verified

August 1, 2022

Enrollment Period

7.9 years

First QC Date

April 3, 2012

Last Update Submit

August 23, 2022

Conditions

Keywords

PTSDPosttraumatic Stress DisorderExposure TherapyProlonged ExposureFear Memory RetrievalCompound extinctionDeepened extinctionPsychotherapy

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in PTSD symptom severity

    PTSD Symptom Scale - Interview Version

    Weeks 6, 10, 22

Secondary Outcomes (4)

  • Change from baseline in depression symptom severity

    Weeks 6, 10, 22.

  • Change from baseline in trauma-related cognitions

    Weeks 6, 10, 22.

  • Change from baseline in general physical and psychological health

    Weeks 6, 10, 22

  • Change from baseline in work, social/leisure activities, and family/home life functioning

    Weeks 6, 10, 22.

Study Arms (3)

Brief Enhanaced Exposure Therapy

EXPERIMENTAL

The following interventions are included in this arm: 1. Psycho-education addressing common reactions to trauma 2. Revisiting the Trauma memories 3. Processing the trauma memories 4. In vivo Exposure homework 5. \*Use of a brief pre-exposure trauma memory retrieval trial 6. Exposure to video clips related to the patient's trauma 7. Compound extinction - simultaneously exposing patient to trauma video clips while they listen to their trauma script

Behavioral: Revisiting the Trauma memoriesBehavioral: Processing the trauma memoriesBehavioral: PsychoeducationBehavioral: Trauma Memory Retrieval TrialBehavioral: Exposure to video clips related to the patient's traumaBehavioral: Exposure HomeworkBehavioral: Compound extinction

Standard Prolonged Exposure Therapy

ACTIVE COMPARATOR

The following interventions are included in this arm: 1. Psycho-education addressing common reactions to trauma 2. Revisiting of the Trauma memories 3. Processing the trauma memories 4. Breathing retraining 5. In vivo Exposure homework

Behavioral: Revisiting the Trauma memoriesBehavioral: Processing the trauma memoriesBehavioral: PsychoeducationBehavioral: Breathing retrainingBehavioral: Exposure Homework

Delayed Treatment Control

NO INTERVENTION

Patients assigned to this arm receive assessment only (Week 0, 3, and 6) prior to receiving standard prolonged exposure therapy using the Foa et al treatment manual.

Interventions

Patient engages in repeated revisiting of their trauma memory under the guidance of the therapist for about 40 minutes. During each revisiting trial the patient closes their eyes and verbally describes the trauma and the feeling and thoughts experienced during the trauma.

Also known as: Trauma Revisiting
Brief Enhanaced Exposure TherapyStandard Prolonged Exposure Therapy

The patient and therapist discuss the patient's experience during the trauma revisiting with the goal of helping the patient gain alternative perspectives of the trauma.

Also known as: Trauma Processing
Brief Enhanaced Exposure TherapyStandard Prolonged Exposure Therapy
PsychoeducationBEHAVIORAL

Through patient handouts and didactic instruction, the patient learns about the common reactions to trauma and the rationale for exposure therapy.

Brief Enhanaced Exposure TherapyStandard Prolonged Exposure Therapy

Prior to the start of Imaginal Exposure, the patient is asked to recall a threatening element of their trauma memory for 1 minute. This is followed by a 30-minute rest-period prior to beginning imaginal exposure.

Also known as: Fear Retrieval
Brief Enhanaced Exposure Therapy

Patient is seated in front of a computer monitor and instructed to view a 30-min looped video clip that thematically resembles the patient's trauma.

Also known as: Exposure to trauma clips
Brief Enhanaced Exposure Therapy

Patient is seated comfortably in a chair and instructed to breathe slowly and deeply in a relaxed manner.

Also known as: Relaxed breathing
Standard Prolonged Exposure Therapy

Therapist assists the patient in identifying trauma-related situations/activities that the patient is avoiding and encourages the patient to begin to confront these situations between sessions.

Also known as: In vivo exposure outside of session
Brief Enhanaced Exposure TherapyStandard Prolonged Exposure Therapy

The patient repeatedly confronts the truama-related media clip while simultaneously listening to their own trauma script through headphones.

Also known as: Deepened Extinction
Brief Enhanaced Exposure Therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current primary PTSD diagnosis based on DSM-IV criteria, with a minimum duration of 12 weeks since the traumatic event.
  • Between the age of 18 and 65.
  • Medication status stable for at least 6 weeks

You may not qualify if:

  • Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by the DSM-IV.
  • Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
  • Current diagnosis of alcohol or substance dependence within the 3 previous months.
  • Unwilling or unable to discontinue current trauma-focused psychotherapy.
  • Ongoing intimate relationship with the perpetrator (in assault-related PTSD cases).
  • Other severe acute or chronic medical or psychiatric condition that, in the judgment of the Medical Director, would make the participant inappropriate for entry.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratory for the Study of Anxiety Disorders, University of Texas at Austin

Austin, Texas, 78712, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Michael J Telch, Ph.D.

    University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 3, 2012

First Posted

April 10, 2012

Study Start

April 1, 2012

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

August 29, 2022

Record last verified: 2022-08

Locations